Cheng Chun-Han, Hao Wen-Rui, Cheng Tzu-Hurng
Department of Medical Education, Linkou Chang Gung Memorial Hospital, Taoyuan City 33305, Taiwan.
Division of Cardiology, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei City 23561, Taiwan.
World J Exp Med. 2024 Dec 20;14(4):98599. doi: 10.5493/wjem.v14.i4.98599.
This editorial discusses the insightful minireview by Rahmati . The minireview delves into the role of the aryl hydrocarbon receptor in the development and progression of esophageal squamous cell carcinoma, highlighting its potential as a promising therapeutic target. The authors concisely summarize the current understanding of how aryl hydrocarbon receptor modulation influences immune responses and the tumor microenvironment, offering fresh perspectives on therapeutic strategies. This editorial aimed to emphasize the significance of these findings and their potential impact on future research and clinical practices for the management of esophageal squamous cell carcinoma.
这篇社论讨论了拉赫马蒂颇具见地的小综述。该小综述深入探讨了芳烃受体在食管鳞状细胞癌发生发展中的作用，强调了其作为一个有前景的治疗靶点的潜力。作者简要总结了目前对芳烃受体调节如何影响免疫反应和肿瘤微环境的理解，为治疗策略提供了新的视角。这篇社论旨在强调这些发现的重要性及其对食管鳞状细胞癌管理的未来研究和临床实践的潜在影响。
